|
Sánchez-del-Campo L, Tárraga A, Montenegro MF, Cabezas-Herrera J, Rodríguez-López JN. Melanoma activation of 3-o-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin to a potent irreversible inhibitor of dihydrofolate reductase. Mol Pharm. 2009 May-Jun;6(3):883-94. doi: 10.1021/mp800259k. PubMed PMID: 19358568.
AÑO: 2009; IF: 5.408
|
19358568
|
Sánchez-del-Campo L, Montenegro MF, Cabezas-Herrera J, Rodríguez-López JN. The critical role of alpha-folate receptor in the resistance of melanoma to methotrexate. Pigment Cell Melanoma Res. 2009 Oct;22(5):588-600. doi: 10.1111/j.1755-148X.2009.00586.x. Epub 2009 Jun 2. PubMed PMID: 19493312.
AÑO: 2009; IF: 3.683
|
|
Sánchez-del-Campo L, Sáez-Ayala M, Chazarra S, Cabezas-Herrera J, Rodríguez-López JN. Binding of natural and synthetic polyphenols to human dihydrofolate reductase. Int J Mol Sci. 2009 Dec 18;10(12):5398-410. doi: 10.3390/ijms10125398. PubMed PMID: 20054477; PubMed Central PMCID: PMC2802001.
AÑO: 2009; IF: 1.387
|
|
Sánchez-del-Campo L, Otón F, Tárraga A, Cabezas-Herrera J, Chazarra S, Rodríguez-López JN. Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate. J Med Chem. 2008 Apr 10;51(7):2018-26. doi: 10.1021/jm701346h. Epub 2008 Mar 7. PubMed PMID: 18324763.
AÑO: 2008; IF: 4.898
|
|
Gonzalez-Muñoz C, Nieto-Cerón S, Cabezas-Herrera J, Hernández-Cascales J. Glucagon increases contractility in ventricle but not in atrium of the rat heart. Eur J Pharmacol. 2008 Jun 10;587(1-3):243-7. doi: 10.1016/j.ejphar.2008.04.001. Epub 2008 Apr 8. PubMed PMID: 18474367.
AÑO: 2008; IF: 2.787
|